| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NSSC | Common Stock | Sale | -$11.1M | -250K | -15.1% | $44.20 | 1.41M | May 8, 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NSSC | Employee Stock Option (Right to Buy) | 100K | May 8, 2024 | Common Stock | 100K | $22.50 | Direct | F3 | |||||
| holding | NSSC | Employee Stock Option (Right to Buy) | 10K | May 8, 2024 | Common Stock | 10K | $26.94 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The shares described herein are subject to a lockup agreement in connection with that certain Underwriting Agreement, dated March 5, 2024, and were also subject to the option to purchase additional shares pursuant to such Underwriting Agreement. Such shares were not purchased pursuant to this option which has expired in accordance with its terms. The reporting person received prior written consent from the representatives of the underwriters to sell the shares in open market transactions. All other shares remain subject to the lockup agreement. |
| F2 | Represents the weighted average selling price of the shares. Actual selling prices ranged from $44.20 through $44.775 per share. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. |
| F3 | Exercisable, cumulatively, at 20% per year commencing October 19, 2021. |
| F4 | Exercisable, cumulatively, at 20% per year commencing August 25, 2022. |